Brain tumors

Acta Oncologica

Volumn 35, Issue SUPPL. 7, 1996, Pages 16-21

  Blomgren, Henric ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN TUMOR; CLINICAL TRIAL; GLIOMA; HUMAN; MENINGIOMA; META ANALYSIS; METASTASIS; PATHOLOGY;

BRAIN NEOPLASMS; GLIOMA; HUMANS; MENINGIOMA;

EID: 0030322757     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841869609101660     Document Type: Article

References (82)

1. Andersen AP, Postoperative irradiation of glioblastomas. Results in a randomized series. Acta Radiol Oncol Radiat Phys Biol 1978; 17 (6): 475-484. (C2/108) (Pubitemid 9128055)
2. Kristiansen K, Hagen S, Kollevold T, et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of bleomycin on survival time. Cancer 1981; 47: 649-652. (Cl/ 118)
3. Walker MD. Alexander E, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 1978; 49: 333-343. (C1/303) (Pubitemid 9013313)
4. Walker MD, Green SB, Byar DP, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. New Engl J Med 1980; 303: 1323-1329. (Cl/358) (Pubitemid 11194457)
5. Sandberg-Wollheim MS, Malmström P, Strömblad L-G. Andersson H. Borgström S, Brun A. Cronqvist S, Hougaard K, Salford LG. A randomized study of chemotherapy with procrbaZine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer 1991; 68: 22-29. (C1/171)
6. Chin HW, Young AB. Maruyama Y. Survival response of malignant gliomas to radiotherapy with or without BCNU or methyl-CCNU chemotherapy at the University of Kentucky Medical Center. Cancer 1981: Treat Rep: 65: 45 -51, (C2/115) (Pubitemid 11047816)
7. Bleechen NM, Stenning SP, A medical research council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytomas. The medical research council brain tumor working party. Br J Cancer 1991; 64: 769-774. (C1/474)
8. Chang CM, Horton J, Schoenfeld D, et al. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint radiation therapy oncology Group and Eastern cooperative oncology Group study. Cancer 1983; 52: 997-1007. (C3/535) (Pubitemid 13050763)
9. Shapiro WR, Green SB, Burger PG, et al. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. J Neurosurg 1989; 71: 19. (C3/571)
10. Shin K, Muller PJ, Geggie PH. Superfractionation radiation therapy in the treatment of malignant glioma. Cancer 1983; 52: 2040-2043. (C1/69) (Pubitemid 14232244)
11. Shin KH, Urbasun RC, Fulton D, et al. Multiple daily fractioning radiation therapy and misonidazole in the anagement of malignant astrocytoma. Cancer 1985: 56: 758 760. (C1/114) (Pubitemid 15228265)
12. Deutsch M, Green SB, Strike TA, et al. Results of a randomized trial comparing BCNU plus radiotherapy. streptozotocin plus radiotherapy. BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. Int J Rad Oncol Biol Phys 1989: 16: 1389-1396. (C1/603) (Pubitemid 19154320)
13. Hatlevoll R, Lindepaard KS, Hagen S, Kristianssen H, et al. Combined modality treatment of operated astrocytoma grade 3 and 4. A prospective and randomized study of misonidazole and radiotherapy with two diffcrent radiation schedules and subsequent CCNU chemotherapy. Cancer 1985: 56: 41 47. (C1/224) (Pubitemid 15022852)
14. Catterall M, Bloom HJG. Ash DV. Walsh L. el al. Fast neutrons compared with megavoltage x-rays in the treatment of patients with supratentorial glioblastomas: A controlled pilot study. Int J Radiat Oncol Biol Phys 1980: 6: 261 -266. (C1 /63) (Pubitemid 10102706)
15. Griffin TW, Davis R, Laramore G, Hendrickson F, et al. Fast neutron radiation therapy for glioblastoma multiforme. Results of an RTOG study. Am J Clin Oncol 1983; 6: 661 -667. (C 1 / 1 66) (Pubitemid 14246200)
16. Griem ML, Chappell R, Wollman RL, Griem M. Outcome analysis of patients treated for high grade gliomas: long term evaluation of mixed beam therapy (Abstract). Int J Radiat Oncol Biol Phys 1989; 17: 233-234. (O2)
17. Kolker JD, Halpern HJ, Krishnasamy S, et al. "Instant-mix" whole brain photon with neutron boost radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 1990; 19: 409-414. (P1/44) (Pubitemid 20299034)
18. Szilka G, Sclienger M, Blond S, et al. Interstitial and combined radiation of supra-tentorial gliomas. Results in 61 cases treated 1973-1981. Acta Neurochir 1984; 33: 355-362. (PI/61)
19. Gutin PH, Leibel SA, Wara WM, et al. Recurrent malignant gliomas: survival following interstitial brachytherapy with high activity iodine-125 sources. J Neurosurg 1987; 67: 864-873. (PI/41) (Pubitemid 18005532)
20. Gutin PH, Philips TL, Hosobuchi Y, et al. Permanent and removable implants for brachy therapy of brain tumors. Int J Radiat Oncol Biol Phys 1981; 7:.1371-1381. (O1) (Pubitemid 12241702)
21. Munniger F, Weigel K. Long-term results of stereotactic interstitial Curie-therapy. Acta Neurochir 1984; 33: 367-371.( O2)
22. van der Schueren E, Ang KK, Notter G, van Glabbeke MA, Vessiere M. EORTC Radiotherapy Cooperative Group, Randomized trial on the effectiveness of high-dose multiple daily fractionation radiotherapy and its combination with a hypoxic cell sensitizer for the treatment of high grade malignant gliomas. EORTG, Brussels (Protocol no 22801). 1981. (O1)
23. Kinsella TJ, Collins J, Rowland J, et al. Pharmacology and phaseI/II study of continuous intravenous infusion of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme. J Clin Oncol 1988; 6: 871-879. (P2/47)
24. Sano K, sato F, Hoshino T, Nagai M. Experimental and clinical studies of radiosensitizers in brain tumors, with a special reference to BUdR-antimetabolite continuous regional infusion radiation therapy. NeuroI Med Clin 1965; 7: 51 -72. (O1)
25. Jubelirer SJ, Rubin M. Shim C, An analysis of 38 cases of low-grade cerebral astrocytoma in adults. WV Med J 1993; 89: 102-105. (R3/38)
26. Kitahara M, Katakura R, Shingai J, et al. Results of supratentorial low-grade astrocytoma. Effects of combined radiochemotherapy. No-Shinkei-Geka 1987; 15: 597-604. (R3/53) (Pubitemid 17107465)
27. Shaw EG, Scheithauer BW, Gilbertson DT, et al. Postoerative radiotherapy of supratentorial low-grade gliomas. Int J Rad Oncol Biol Phys 1989; 16: 663-668. (R2/49) (Pubitemid 19079702)
28. Whitton AC, Bloom HJG. Low-grade glioma of the cerebral hemispheres in adults: A retrospective analysis of 88 cases. Int J Rad Oncol Biol Phys 1990; 18: 783-786. (R3/60) (Pubitemid 20154033)
29. Steiger HJ, Markwalden RV. Seiler RW, Ebeling U, Reulen HJ, Early prognosis of supratentorial grade 2 astrocytomas in adult patients after resection or stereotactic biopsy. An analysis of 50 cases operated on between 1984 and 1988. Acta Neurochir-Wien 1990; 106: 99-105. (R3/50)
30. Weir BR, Grace M. The relative significance of factors affecting post-operative survival in astrocytomas, grades I and II. Can J Neurol Sci 1976; 3: 47-50. (RI/107)
31. Medbery CA, Straus K. Steinberg SM, et al. Low-grade astrocytomas: treatment results and prognostic vaiables. Int J Rad Oncol Biol Phys 1988; 15: 837-841. (R2/50)
32. Laws ER, Taylor WF, Clifton MB, Okazaku H. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 1984; 61: 665-673. (R2/461) (Pubitemid 14009855)
33. Shaw EG. Daumas-Dupont C, Sheithauer BW, et al. Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 1989; 70: 853-61. (R1/91) (Pubitemid 19150501)
34. Wechster-Jentzsch K, Witt HJH, Fitz CR, McCullough DC, Harisiadis L. Unresectable gliomas in children: tumour volume response to radiation therapy. Radiology 1988; 169: 237-242. (P1/12)
35. Barbaro NM, Gutin PN, Wilson CB, Sheline GE, Boldrey EB, Wara WM. Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 1987; 20: 525-528. (Rl/84) (Pubitemid 17069668)
36. Taylor BW, Marcus RB, Friedman WA. Ballinger WE, Million RR. The meningioma controversy: Postoperative radiation therapy. Int J Rad Oncol Biol Phys 1988; 15: 299-304. (R 1/132)
37. Posner JB. Management of central nervous system metastases. Semin Oncol 1977; 4: 81-91. (O1) (Pubitemid 8071003)
38. Dunlap HF. Metastatic malignant tumors of the brain. Ann Int Med 1932; 5: 1274-1288. (O2)
39. Kiefer EJ, Metastatic brain tumors. (M Sc Thesis). University of Minnesota, 1947. (O2)
40. Lenz M, Freid JR. Metastases to the skeleton, brain and spinal cord from cancer of the breast and effect of radiotherapy. Ann Surg 1931; 93: 278-293. (01/3)
41. Dyke CG, Davidoff LM. Roentgentherapy of diseases of the nervous system. London: Henry Kimpton, 1942. (01/3)
42. Chao J-H, Pillips R. Nickson JJ, Roentgen-ray therapy of cerebral metastases. Cancer 1954; 1: 682-689. (R1/38)
43. Chu FCH, HiIaris BB, Value of radiation therapy in the management of intracranial metastases. Cancer 1961; 14: 577-581. (RI /218)
44. Order SE. Hellman S, von Essen CF, Kligerman MM. Improvement in quality of survival following whole-brain irradiation for brain metastases. Radiology 1968; 91: 149-153. (R1/108)
45. Horton J, Baxter DH, Olsson KB. The management of metastases to the brain by irradiation and corticosteroids. Am J Roentgenol Radium Ther Nucl Med 1971; 111: 334-336. (R2/48)
46. Nisce LZ, Hilaris BS, Chu FCH. A review of experience with irradiation of brain metastasis. Am J Roentgenol Radium Ther Nucl Med 1971; III : 329-333. (O2)
47. Montana GS, Meacham WF, Caldwell WL. Brain irradiation for metastatic disease of lung origin. Cancer 1972; 29: 1477-1480. (R2/62)
48. Hindo WA, De Trana FA, Lee MS, Hendrickson FR. Large dose increment irradiation in treatment of cerebral metastases. Cancer 1970; 26: 138-141. (R1/44)
49. Shehata WM, Hendrickson FR, Hindo WA. Rapid fractionation technique and retreatment of cerebral metastases by irradiation. Cancer 1974, 34: 257-161. (R1/81)
50. West J, Maor M. Intracranial metastases: Behavioural patterns related to primary site and results of treatment by whole brain irradiation. Int J Rad Oncol Biol Phys 1980; 6: 11-15. (RI/350) (Pubitemid 10103010)
51. Kramer S, Hendrickson F, Zelen M, Schotz W, Therapeutic trials in the management of metastatic brain tumors by different timeidose fraction schemes of radition therapy. Natl Cancer Inst Monograph 1977; 46: 213-221. (C3/1994)
52. Borglet B, Gelber R, Kramer S, Brady LW, et al. The palliation of brain metastases: Final results of the first two studies by the Radiation Therapy Oncology Group, Int J Rad Oncol Biol Phys 1980; 6: 1 -9. (C1 /1994) (Pubitemid 10103009)
53. Gelber RD, Larson M, Borgelt BB, Kramer S, Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favourable prognosis. Cancer 1981: 48: 1749- 1753. (C1 /1994) (Pubitemid 11022876)
54. Kurtz JM. Gelber R, Brady LW, Carella ZJ, Cooper JS, The palliation of brain metastases in a favourable patient population. A randomized clinical trial by the Radiation Therapy Oncology Group, Int J Rad Oncol Biol Phys 1981; 7: 891-895. (C1/309) (Pubitemid 11017318)
55. Biti G, Santoni R, Ponticelli P, Magrini S, Mungar V. Multiple daily fractionation in cerebral metastases. In: Proceedings of the Third European Conference on Clinical Oncology and Cancer Nursing, 1985 Stockholm, Federation of European Cancer Societies, 1985. (O1)
56. Sause WT, Scott C, Krisch B, Rotman M. RTOG 85 28: accelerated fractionation in the treament of patients with supratentorial brain metastases. In: Proceedings of the 73rd Annual Meeting of the America Radium Society. April 1991. Philadelphia: American Radium Society Inc, 1991: 17 (Cl/345)
57. Epstein BE, Scott CB, Sause WT, Rotman M, et al. Improved survival duration in patients with unresected solitary brain metastases using accelerated hyperfractionated radiation therapy at total doses of 54.4 Gy and greater. Cancer 1993; 71: 1362-1367. (C1/159) (Pubitemid 23054932)
58. Hoskin PJ, Crow J, Ford HT. The influence of extent and local management on the outcome of radiotherapy for brain metastases. Int J Rad Oncol Biol Phys 1990; 19: 111-115.(R1/164) (Pubitemid 20239793)
59. Aiken R. Leavengood JM, Kim JH, Deck MD, Thaler HT, Posner JB. Metronidazole in the treatment of metastatic brain tumors. Results of a controlled clinical trial. J Neurooncol 1984; 2: 105-111. (C1/50) (Pubitemid 14050551)
60. Eyre HJ, Ohlsen JD, Frank J, LoBuglio AF, McCracken JD. Weatherall TJ, Mansfield CM. Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment of metastatic cancer to the brain. A Southwest Oncology Group Study. J Neurooncol 1984; 2: 325-330. (C2/116) (Pubitemid 15191842)
61. DeAngelis LM, Currie VE, Kim JM, Krol G, O'Hehir MA. Farag FM. Young SW, Posner JB. The combined use of radiation therapy and lonidamine in the treatment of brain metastases. J Neurooncol 1989: 7: 241-247. (C2/58) (Pubitemid 19225514)
62. Komarnicky LT, Pillips TL, Martz K, Asbell S, Isaacson S, Urtrasun R. A randomized phase III protocol for the evaluatiuon of misonidazole combined with radiation in the treatment of patients with brain metastases. (RTOG-7916). Int J Radiat Oncol Biol Phys 1991; 20: 53-58. (C2/859)
63. Fager CA. Indications for neurosurgical intervention in metastatic lesions of the central nervous system. Med Clin Amer 1975: 59: 487-494. (O2)
64. Galicich JH, Sundaresan N, Arbit E, Passe S, Surgical treatment of single brain metastasis: Factors associated with survival. Cancer 1980; 45: 381-386. (O1) (Pubitemid 10212209)
65. Haar F. Patterson RH. Surgery for metastatic intracranial neoplasm. Cancer 1972; 30: 1241-1244. (O2)
66. Hendricks GL. Hood HL. Seven-year cure of lung cancer with metastases to the brain. JAMA 1972; 220: 127-128. (O2)
67. Lang EF, Slater JJ, Metastatic brain tumors. Results of surgical and non-surgical treatment. Surg Ciin No Amer 1964; 44: 865 - 872.(O3)
68. Richard P, McKissock W, lntracranial metastases. Brit Med J 1963; I : 15-18. (O2)
69. Dosoretz DE. Blizer PH, Russell AH. Wang CC, Management of solitary metastasis to the brain: The role of elective brain irradiation following complete surgical resection. Int J Rad Oncol Biol Phys 1980; 6: 1727-1730. (R3/21) (Pubitemid 11137184)
70. Patchell RA, Cirrincione C, Thaler HT, Galicich JH, Kim JH, Posner JB. Single brain metastases: Surgery plus radiation or radiation alone. Neurology 1986; 36: 447-453. (R3/43) (Pubitemid 16069996)
71. Smalley SR, Schray MF. Laws ER. O'Fallon JR. Adjuvant radiation therapy after surgical resection of solitary brain metastasis: Association with pattern of Failure and survival. Int J Rad Oncol Biol Phys 1987; 13: 1611-1616. (R1/85) (Pubitemid 17160121)
72. DeAngelis LM, Mandell LR, Thaler HT, Kimmel DW, Galicich JH. The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery 1989; 24(6): 798-805. (R1/98) (Pubitemid 19157082)
73. Mandell L, Hilaris B Sullivan M, Sundaresan N, Nori D, Kim J-H, Martini N. Fuks Z. The treatment of single brain metastasis from non-oat cell lung carcinoma: Surgery and radiation versus radiation therapy alone. Cancer 1986; 58: 641-649. (P2/104) (Pubitemid 16072065)
74. Katz HR. The relative effectiveness of radiation therapy. coricosteroids and surgery in the management of melanoma metastatic to the central nervous system. Int J Rad Oncol Biol Phys 1981; 7: 897-906. (R3/36) (Pubitemid 11017319)
75. Sause WT, Crowley JJ, Morantz R. et al. Solitary brain metastases: Results of an RTOG/SWOG protocol evaluation. Surgery plus RT versus RT alone. Am J Clin Oncol 1990: 13: 427-432. (P1/97) (Pubitemid 20344521)
76. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. The New Engl J Med 1990; 322: 494-500. (C1/48) (Pubitemid 20067825)
77. Kihlström L, Karlsson B. Lundquist C, Gamma knife surgery for cerebral metastases. Implications for survival based on 16 years experience. In: Gildenberg L. Karger AG, eds. Stereotactic and Functional Neurosurgery. Basel. 1993; 61 (Suppl 1) : 45-50. (P1/160) (Pubitemid 24032056)
78. Flickinger JC, Kondziolka D. Lunsford D. Coffey RJ, et al. A multiinstitutional experience with stereotactic radiosurgery for solitary brain metastases. Int J Rad Oncol Biol Phys 1994. 28: 797-802. (P1/116) (Pubitemid 24099860)
79. Sturm V, Kober B, Höver K-H, Schlegel W, et al. Stereotactic percutaneous single dose irradiation of brain metastases with a linear acceleator. Int J Rad Oncol Biol Phys 1987: 13: 279-282. (P2/13) (Pubitemid 17033844)
80. Loeffler JS, Kooy HM, Wen PY, Fine HA. et al. The treatment of recurrent brain tumors with stereotactic radiosurgery. J Clin Oncol 1990; 8: 576-580. (P1/18)
81. Adler JR. Cox RS, Kaplan I. Martin DP, Stereotactic radiosurgery treatment of brain metastases. J Neurosurg 1992; 76: 444-449. (P1/33)
82. Fuller BG. Kaplan ID. Adler J, Cox RS, Bagshaw MA. Stereotactic radiosurgery for brain metastases: The importance of adjuvant whole brain irradiation. Int J Rad Oncol Biol Phys 1992; 23: 413-418. (PI/33)